Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Alembic Ltd
NSE:ALEMBICLTD

Watchlist Manager
Alembic Ltd Logo
Alembic Ltd
NSE:ALEMBICLTD
Watchlist
Price: 94.42 INR 2.43% Market Closed
Market Cap: ₹24.2B
Write Note Create Alert Ask AI

Relative Value

The Relative Value of one ALEMBICLTD stock under the Base Case scenario is hidden INR. Compared to the current market price of 94.42 INR, Alembic Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALEMBICLTD Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

P/S
View Details
P/E
View Details
P/OCF
View Details
P/FCFE
View Details
P/B
View Details
EV/S
View Details
EV/GP
View Details
EV/EBITDA
View Details
EV/EBIT
View Details
EV/OCF
View Details
EV/FCFF
View Details
EV/IC
View Details

Multiples Across Competitors

ALEMBICLTD Competitors Multiples
Alembic Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Alembic Ltd
NSE:ALEMBICLTD
24.2B INR 10.8 7.5 24.3 27.4
US
Eli Lilly and Co
NYSE:LLY
985.1B USD 16.6 53.5 35.9 38.5
US
Johnson & Johnson
NYSE:JNJ
554.2B USD 5.9 20.7 14.4 17.7
CH
Roche Holding AG
SIX:ROG
283.2B CHF 4.6 30.1 12.7 14.8
UK
AstraZeneca PLC
LSE:AZN
214.8B GBP 5.1 31.6 15.1 22.1
CH
Novartis AG
SIX:NOVN
224.7B CHF 5.2 20.1 12.7 16.3
US
Merck & Co Inc
NYSE:MRK
281.3B USD 4.4 14.8 10.4 12.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.2 16 11.1 12.9
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
US
Pfizer Inc
NYSE:PFE
150.9B USD 2.4 15.4 7.7 10.6
FR
Sanofi SA
PAR:SAN
97.3B EUR 1.7 8.2 7.6 7.6
P/E Multiple
Earnings Growth PEG
IN
Alembic Ltd
NSE:ALEMBICLTD
Average P/E: 21.8
7.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.5
54%
1
US
Johnson & Johnson
NYSE:JNJ
20.7
6%
3.4
CH
Roche Holding AG
SIX:ROG
30.1
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.6
38%
0.8
CH
Novartis AG
SIX:NOVN
20.1
17%
1.2
US
Merck & Co Inc
NYSE:MRK
14.8
14%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
16
2%
8
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
US
Pfizer Inc
NYSE:PFE
15.4
27%
0.6
FR
Sanofi SA
PAR:SAN
8.2
1%
8.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Alembic Ltd
NSE:ALEMBICLTD
Average EV/EBITDA: 44.1
24.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.9
34%
1.1
US
Johnson & Johnson
NYSE:JNJ
14.4
2%
7.2
CH
Roche Holding AG
SIX:ROG
12.7
5%
2.5
UK
AstraZeneca PLC
LSE:AZN
15.1
10%
1.5
CH
Novartis AG
SIX:NOVN
12.7
6%
2.1
US
Merck & Co Inc
NYSE:MRK
10.4
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
11.1
1%
11.1
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.7
0%
N/A
FR
Sanofi SA
PAR:SAN
7.6
8%
1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
Alembic Ltd
NSE:ALEMBICLTD
Average EV/EBIT: 92.3
27.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.5
37%
1
US
Johnson & Johnson
NYSE:JNJ
17.7
6%
2.9
CH
Roche Holding AG
SIX:ROG
14.8
6%
2.5
UK
AstraZeneca PLC
LSE:AZN
22.1
23%
1
CH
Novartis AG
SIX:NOVN
16.3
12%
1.4
US
Merck & Co Inc
NYSE:MRK
12.4
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
12.9
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
835.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.6
7%
1.5
FR
Sanofi SA
PAR:SAN
7.6
6%
1.3

See Also

Summary
ALEMBICLTD intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALEMBICLTD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALEMBICLTD stock valuation using valuation multiples.
Wall Street Estimates
ALEMBICLTD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALEMBICLTD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 314,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.